← Every company
Bristol-Myers Squibb Co Lobbying
What Bristol-Myers Squibb Co discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
BMY on carbonthat →Disclosed spend
$5.5M
across every filing on file
Filings
25
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesMedicare/MedicaidTrade (domestic/foreign)PharmacyTaxation/Internal Revenue CodeCopyright/Patent/Trademark
25 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | BRISTOL-MYERS SQUIBB COMPANYTrade (domestic/foreign)Health Issues | $3.2M |
| 20261st Quarter (Jan 1 - Mar 31) | BRISTOL-MYERS SQUIBB COMPANYHealth IssuesMedicare/Medicaid | $1.3M |
| 20262nd Quarter (Apr 1 - June 30) | WILLIAMS AND JENSEN, PLLCHealth IssuesMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | THE MCMANUS GROUPMedicare/Medicaid | $80K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesMedicare/Medicaid | $80K |
| 20262nd Quarter (Apr 1 - June 30) | THE MCMANUS GROUPMedicare/MedicaidHealth Issues | $80K |
| 20262nd Quarter (Apr 1 - June 30) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $80K |
| 20262nd Quarter (Apr 1 - June 30) | CAPITOL COUNSEL LLCHealth IssuesMedical/Disease Research/Clinical Labs | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | SPLITOAK STRATEGIES LLCMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | MARSHALL & POPP, LLCPharmacy | $60K |
| 20262nd Quarter (Apr 1 - June 30) | SPLITOAK STRATEGIES LLCMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | W STRATEGIES, LLCHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | TODD STRATEGY GROUPHealth IssuesMedicare/Medicaid | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL COUNSEL LLCHealth IssuesMedical/Disease Research/Clinical Labs | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCPharmacy | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | W STRATEGIES, LLCHealth Issues | $30K |
| 20261st Quarter (Jan 1 - Mar 31) | AVENUE SOLUTIONSHealth IssuesMedicare/Medicaid | — |
| 20261st Quarter (Jan 1 - Mar 31) | W STRATEGIES, LLCHealth Issues | — |
| 20261st Quarter (Jan 1 - Mar 31) | MILLER STRATEGIES, LLCHealth IssuesMedicare/Medicaid | — |
| 20261st Quarter (Jan 1 - Mar 31) | MARSHALL & POPP, LLCPharmacyTrade (domestic/foreign) | — |
| 20261st Quarter (Jan 1 - Mar 31) | CROSSROADS STRATEGIES, LLC | — |
| 20262nd Quarter (Apr 1 - June 30) | MILLER STRATEGIES, LLCHealth IssuesMedicare/Medicaid | — |
| 20261st Quarter (Jan 1 - Mar 31) | CAPITOL COUNSEL LLCHealth IssuesMedical/Disease Research/Clinical Labs | — |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on BMY
Company overviewEverything on BMY in one place, with the price.SEC filingsWhat BMY's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat BMY's own officers and directors buy and sell.Who owns itEvery manager reporting a position in BMY.Funds holding itWhich funds and ETFs hold BMY, and how big a bet.Who lobbies for itThe lobbyists on BMY's account, and who they worked for.Federal contractsWhat federal agencies pay BMY.PatentsWhat BMY is filing at the patent office.